Refine by
Type I Diabetes Articles & Analysis: This-Year
3 news found
Protheragen-ING, a distinguished name in the realm of pharmaceutical innovation, has proudly announced its most sought-after Active Pharmaceutical Ingredients (APIs). Known for offering tailored technical research and development services to researchers globally, Protheragen-ING emphasizes its commitment to pioneering advancement in pharmaceutical sciences. Among the top APIs highlighted are ...
We’re starting the week by welcoming Rebecca Warfvinge and João Vieira to the BPC team! Both join us as Technical Sales Scientists, bringing research expertise that will help our customers advance their work. Rebecca holds a master’s degree in biomedicine and has since conducted research for several years at Lund University in leukemia, where she used single-cell methods to ...
Ace Therapeutics launches its cutting-edge in vivo models of diabetes mellitus. These models—chemically induced, genetically engineered, or diet-induced—have the potential to advance diabetes research by giving scientists the means to support the identification and development of novel treatment approaches. Diabetes mellitus, a chronic condition characterized by elevated blood ...